Clinical Trials Browser

Recruiting × Paget Disease, Extramammary × Clear all

Disease, Paget Disease, Extramammary

NCT06873815 2026-01-12

A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)

Phase 2 Recruiting

27 enrolled

Paget Disease, Extramammary

NCT07309770 2025-12-30

Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies

Phase 2 Recruiting

90 enrolled

Urachal cancer, Paget Disease, Extramammary

NCT05859074 2025-12-03

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Phase 1 Recruiting

56 enrolled

DermatologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Hemangiosarcoma, Melanoma, Neoplasm Metastasis, Neoplasms, Paget Disease, Extramammary, Sarcoma, Kaposi, Skin Neoplasms, Carcinoma, Merkel Cell, Adenocarcinoma, Sebaceous, Carcinoma, Skin Appendage

NCT06683846 2025-08-24

Ivonescimab in the Treatment of Multiple Advanced Tumors

Phase 2 Recruiting

400 enrolled

CNSDermatologicEndocrineGenitourinarySarcoma

Urachal cancer, Carcinoma, Carcinoma, Basal Cell, Carcinoma, Transitional Cell, Kidney Neoplasms, Paget Disease, Extramammary, Paraganglioma, Penile Neoplasms, Pheochromocytoma, Prostatic Neoplasms, Rhabdomyosarcoma, Sarcoma, Angiomyolipoma, Carcinoma, Neuroendocrine, Perivascular Epithelioid Cell Neoplasms

NCT07117851 2025-08-12

A Study of Disitamab Vedotin + Bicalutamide in HER2/AR-Positive Scrotal Paget's Disease

Phase 2 Recruiting

20 enrolled

Paget Disease, Extramammary

NCT03713203 2025-04-06

PAGETEX

Phase NA Recruiting

24 enrolled

Paget Disease, Extramammary

NCT06791070 2025-01-24

RC48&J for EPD

Phase 2 Recruiting

20 enrolled

Paget Disease, Extramammary

NCT06684327 2024-12-20

Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors

Phase 2 Recruiting

100 enrolled

GenitourinarySarcoma

Urachal cancer, Paget Disease, Extramammary, Penile Neoplasms, Rhabdomyosarcoma, Testicular Neoplasms

NCT06561555 2024-12-17

A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease.

Phase 2 Recruiting

36 enrolled

Paget Disease, Extramammary

Clinical Trials

Gynecologic Extramammary Paget's Disease

A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)

Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Ivonescimab in the Treatment of Multiple Advanced Tumors

A Study of Disitamab Vedotin + Bicalutamide in HER2/AR-Positive Scrotal Paget's Disease

PAGETEX

RC48&J for EPD

Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors

A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease.